abstract |
The present invention is concerned with the use of at least one immunosuppressant, or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, in the treatment of reversible obstructive respiratory disease, in particular asthma, and/or atopic dermatitis, and compositions suitable for such use. |